nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP2D6—Lomustine—brain cancer	0.137	0.191	CbGbCtD
Ranitidine—CYP1A2—Carmustine—brain cancer	0.135	0.189	CbGbCtD
Ranitidine—CYP2D6—Hydroxyurea—brain cancer	0.104	0.145	CbGbCtD
Ranitidine—CYP3A4—Temozolomide—brain cancer	0.102	0.143	CbGbCtD
Ranitidine—CYP3A4—Lomustine—brain cancer	0.087	0.122	CbGbCtD
Ranitidine—CYP3A5—Etoposide—brain cancer	0.0539	0.0754	CbGbCtD
Ranitidine—CYP1A2—Etoposide—brain cancer	0.0401	0.0561	CbGbCtD
Ranitidine—ABCB1—Etoposide—brain cancer	0.0351	0.0491	CbGbCtD
Ranitidine—CYP3A4—Etoposide—brain cancer	0.021	0.0294	CbGbCtD
Ranitidine—Nephrotoxicity—Lomustine—brain cancer	0.0141	0.0637	CcSEcCtD
Ranitidine—SLC22A8—choroid plexus—brain cancer	0.0127	0.408	CbGeAlD
Ranitidine—Nephropathy toxic—Lomustine—brain cancer	0.0078	0.0353	CcSEcCtD
Ranitidine—Nephrotoxicity—Carmustine—brain cancer	0.0056	0.0253	CcSEcCtD
Ranitidine—Emotional distress—Hydroxyurea—brain cancer	0.00518	0.0234	CcSEcCtD
Ranitidine—Meningitis—Carmustine—brain cancer	0.00459	0.0208	CcSEcCtD
Ranitidine—Haematemesis—Procarbazine—brain cancer	0.00409	0.0185	CcSEcCtD
Ranitidine—Bone marrow depression—Hydroxyurea—brain cancer	0.00326	0.0147	CcSEcCtD
Ranitidine—Nephropathy toxic—Carmustine—brain cancer	0.0031	0.014	CcSEcCtD
Ranitidine—Nephropathy—Etoposide—brain cancer	0.00289	0.0131	CcSEcCtD
Ranitidine—Pancytopenia—Lomustine—brain cancer	0.00267	0.0121	CcSEcCtD
Ranitidine—Gynaecomastia—Procarbazine—brain cancer	0.00254	0.0115	CcSEcCtD
Ranitidine—SLC22A1—ganglion—brain cancer	0.00252	0.0809	CbGeAlD
Ranitidine—Nephropathy toxic—Etoposide—brain cancer	0.0024	0.0108	CcSEcCtD
Ranitidine—Photosensitivity—Procarbazine—brain cancer	0.00235	0.0106	CcSEcCtD
Ranitidine—Alopecia—Lomustine—brain cancer	0.00199	0.00899	CcSEcCtD
Ranitidine—Dysphagia—Procarbazine—brain cancer	0.00178	0.00807	CcSEcCtD
Ranitidine—Hepatic failure—Hydroxyurea—brain cancer	0.00178	0.00804	CcSEcCtD
Ranitidine—Eosinophilia—Procarbazine—brain cancer	0.00177	0.00799	CcSEcCtD
Ranitidine—Leukopenia—Lomustine—brain cancer	0.00175	0.00793	CcSEcCtD
Ranitidine—Pancreatitis—Procarbazine—brain cancer	0.00175	0.00791	CcSEcCtD
Ranitidine—Musculoskeletal pain—Temozolomide—brain cancer	0.00174	0.00787	CcSEcCtD
Ranitidine—Angina pectoris—Procarbazine—brain cancer	0.00174	0.00786	CcSEcCtD
Ranitidine—Pancytopenia—Procarbazine—brain cancer	0.00169	0.00766	CcSEcCtD
Ranitidine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00165	0.0512	CbGpPWpGaD
Ranitidine—Photosensitivity reaction—Procarbazine—brain cancer	0.00163	0.00736	CcSEcCtD
Ranitidine—Aplastic anaemia—Temozolomide—brain cancer	0.00161	0.0073	CcSEcCtD
Ranitidine—Pneumonia—Procarbazine—brain cancer	0.0016	0.00724	CcSEcCtD
Ranitidine—Gynaecomastia—Carmustine—brain cancer	0.00159	0.0072	CcSEcCtD
Ranitidine—Thrombocytopenia—Lomustine—brain cancer	0.00157	0.00708	CcSEcCtD
Ranitidine—Pain—Carboplatin—brain cancer	0.00156	0.00706	CcSEcCtD
Ranitidine—Jaundice—Procarbazine—brain cancer	0.00155	0.00701	CcSEcCtD
Ranitidine—Sweating—Procarbazine—brain cancer	0.00153	0.0069	CcSEcCtD
Ranitidine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0015	0.0466	CbGpPWpGaD
Ranitidine—Blood creatinine increased—Hydroxyurea—brain cancer	0.0015	0.00677	CcSEcCtD
Ranitidine—Body temperature increased—Carboplatin—brain cancer	0.00144	0.00653	CcSEcCtD
Ranitidine—Breast disorder—Hydroxyurea—brain cancer	0.00144	0.00653	CcSEcCtD
Ranitidine—Hallucination—Procarbazine—brain cancer	0.00142	0.00643	CcSEcCtD
Ranitidine—Hepatic failure—Temozolomide—brain cancer	0.00139	0.00628	CcSEcCtD
Ranitidine—Pancreatitis—Hydroxyurea—brain cancer	0.00135	0.00612	CcSEcCtD
Ranitidine—Pancytopenia—Hydroxyurea—brain cancer	0.00131	0.00593	CcSEcCtD
Ranitidine—Neutropenia—Hydroxyurea—brain cancer	0.00129	0.00584	CcSEcCtD
Ranitidine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00129	0.0399	CbGpPWpGaD
Ranitidine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00128	0.0397	CbGpPWpGaD
Ranitidine—Arrhythmia—Procarbazine—brain cancer	0.00128	0.00577	CcSEcCtD
Ranitidine—Body temperature increased—Lomustine—brain cancer	0.00126	0.00571	CcSEcCtD
Ranitidine—Alopecia—Procarbazine—brain cancer	0.00126	0.00571	CcSEcCtD
Ranitidine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00118	0.0365	CbGpPWpGaD
Ranitidine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00117	0.0363	CbGpPWpGaD
Ranitidine—Anaemia—Procarbazine—brain cancer	0.00115	0.0052	CcSEcCtD
Ranitidine—Breast disorder—Temozolomide—brain cancer	0.00113	0.0051	CcSEcCtD
Ranitidine—Dysphagia—Carmustine—brain cancer	0.00112	0.00505	CcSEcCtD
Ranitidine—Leukopenia—Procarbazine—brain cancer	0.00111	0.00503	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.0011	0.00498	CcSEcCtD
Ranitidine—Hallucination—Hydroxyurea—brain cancer	0.0011	0.00497	CcSEcCtD
Ranitidine—Dysphagia—Temozolomide—brain cancer	0.00108	0.00488	CcSEcCtD
Ranitidine—Pancytopenia—Carmustine—brain cancer	0.00106	0.00479	CcSEcCtD
Ranitidine—Myalgia—Procarbazine—brain cancer	0.00106	0.00479	CcSEcCtD
Ranitidine—Arthralgia—Procarbazine—brain cancer	0.00106	0.00479	CcSEcCtD
Ranitidine—Neutropenia—Carmustine—brain cancer	0.00104	0.00472	CcSEcCtD
Ranitidine—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00102	0.0318	CbGpPWpGaD
Ranitidine—Pancytopenia—Temozolomide—brain cancer	0.00102	0.00463	CcSEcCtD
Ranitidine—Confusional state—Procarbazine—brain cancer	0.00102	0.00463	CcSEcCtD
Ranitidine—Vomiting—Lomustine—brain cancer	0.00102	0.00459	CcSEcCtD
Ranitidine—Neutropenia—Temozolomide—brain cancer	0.00101	0.00456	CcSEcCtD
Ranitidine—Pneumonia—Carmustine—brain cancer	0.001	0.00453	CcSEcCtD
Ranitidine—Erectile dysfunction—Temozolomide—brain cancer	0.000994	0.00449	CcSEcCtD
Ranitidine—Thrombocytopenia—Procarbazine—brain cancer	0.000994	0.00449	CcSEcCtD
Ranitidine—Tachycardia—Procarbazine—brain cancer	0.00099	0.00448	CcSEcCtD
Ranitidine—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000986	0.0306	CbGpPWpGaD
Ranitidine—Photosensitivity reaction—Temozolomide—brain cancer	0.000985	0.00445	CcSEcCtD
Ranitidine—Hyperhidrosis—Procarbazine—brain cancer	0.000981	0.00444	CcSEcCtD
Ranitidine—Alopecia—Hydroxyurea—brain cancer	0.000977	0.00442	CcSEcCtD
Ranitidine—Weight decreased—Temozolomide—brain cancer	0.000976	0.00441	CcSEcCtD
Ranitidine—SLC22A1—telencephalon—brain cancer	0.000972	0.0312	CbGeAlD
Ranitidine—Pneumonia—Temozolomide—brain cancer	0.000968	0.00437	CcSEcCtD
Ranitidine—Erythema—Hydroxyurea—brain cancer	0.000962	0.00435	CcSEcCtD
Ranitidine—HRH2—endocrine gland—brain cancer	0.000951	0.0306	CbGeAlD
Ranitidine—Cardiac arrest—Etoposide—brain cancer	0.00095	0.00429	CcSEcCtD
Ranitidine—Nausea—Lomustine—brain cancer	0.000949	0.00429	CcSEcCtD
Ranitidine—Hypotension—Procarbazine—brain cancer	0.000948	0.00429	CcSEcCtD
Ranitidine—HRH2—head—brain cancer	0.000939	0.0302	CbGeAlD
Ranitidine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000925	0.00418	CcSEcCtD
Ranitidine—Insomnia—Procarbazine—brain cancer	0.000918	0.00415	CcSEcCtD
Ranitidine—Somnolence—Procarbazine—brain cancer	0.000902	0.00408	CcSEcCtD
Ranitidine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000893	0.00404	CcSEcCtD
Ranitidine—Anaemia—Hydroxyurea—brain cancer	0.000889	0.00402	CcSEcCtD
Ranitidine—Hallucination—Carmustine—brain cancer	0.000889	0.00402	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000881	0.00398	CcSEcCtD
Ranitidine—Malaise—Hydroxyurea—brain cancer	0.000868	0.00392	CcSEcCtD
Ranitidine—Pain—Procarbazine—brain cancer	0.000868	0.00392	CcSEcCtD
Ranitidine—Constipation—Procarbazine—brain cancer	0.000868	0.00392	CcSEcCtD
Ranitidine—Hepatitis—Temozolomide—brain cancer	0.000864	0.0039	CcSEcCtD
Ranitidine—Dysphagia—Etoposide—brain cancer	0.000863	0.0039	CcSEcCtD
Ranitidine—Leukopenia—Hydroxyurea—brain cancer	0.000861	0.00389	CcSEcCtD
Ranitidine—Hallucination—Temozolomide—brain cancer	0.000859	0.00388	CcSEcCtD
Ranitidine—HRH2—central nervous system—brain cancer	0.000857	0.0276	CbGeAlD
Ranitidine—CYP2D6—hindbrain—brain cancer	0.000857	0.0275	CbGeAlD
Ranitidine—Bronchospasm—Etoposide—brain cancer	0.000849	0.00384	CcSEcCtD
Ranitidine—Feeling abnormal—Procarbazine—brain cancer	0.000836	0.00378	CcSEcCtD
Ranitidine—Pancytopenia—Etoposide—brain cancer	0.00082	0.00371	CcSEcCtD
Ranitidine—Erythema multiforme—Temozolomide—brain cancer	0.000817	0.00369	CcSEcCtD
Ranitidine—Discomfort—Hydroxyurea—brain cancer	0.000809	0.00366	CcSEcCtD
Ranitidine—Neutropenia—Etoposide—brain cancer	0.000807	0.00365	CcSEcCtD
Ranitidine—Urticaria—Procarbazine—brain cancer	0.000806	0.00364	CcSEcCtD
Ranitidine—Body temperature increased—Procarbazine—brain cancer	0.000802	0.00363	CcSEcCtD
Ranitidine—Abdominal pain—Procarbazine—brain cancer	0.000802	0.00363	CcSEcCtD
Ranitidine—Arrhythmia—Carmustine—brain cancer	0.000798	0.00361	CcSEcCtD
Ranitidine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000792	0.0246	CbGpPWpGaD
Ranitidine—Alopecia—Carmustine—brain cancer	0.00079	0.00357	CcSEcCtD
Ranitidine—Erythema—Carmustine—brain cancer	0.000778	0.00352	CcSEcCtD
Ranitidine—Pneumonia—Etoposide—brain cancer	0.000774	0.0035	CcSEcCtD
Ranitidine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000769	0.00348	CcSEcCtD
Ranitidine—Alopecia—Temozolomide—brain cancer	0.000763	0.00345	CcSEcCtD
Ranitidine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000762	0.0237	CbGpPWpGaD
Ranitidine—Erythema—Temozolomide—brain cancer	0.000752	0.0034	CcSEcCtD
Ranitidine—Jaundice—Etoposide—brain cancer	0.00075	0.00339	CcSEcCtD
Ranitidine—Hypersensitivity—Procarbazine—brain cancer	0.000748	0.00338	CcSEcCtD
Ranitidine—Vision blurred—Carmustine—brain cancer	0.000733	0.00331	CcSEcCtD
Ranitidine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000729	0.0226	CbGpPWpGaD
Ranitidine—Anaemia—Carmustine—brain cancer	0.000719	0.00325	CcSEcCtD
Ranitidine—Agranulocytosis—Etoposide—brain cancer	0.000718	0.00325	CcSEcCtD
Ranitidine—Pruritus—Procarbazine—brain cancer	0.000718	0.00325	CcSEcCtD
Ranitidine—Agitation—Carmustine—brain cancer	0.000715	0.00323	CcSEcCtD
Ranitidine—Vision blurred—Temozolomide—brain cancer	0.000709	0.0032	CcSEcCtD
Ranitidine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000704	0.0218	CbGpPWpGaD
Ranitidine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000701	0.0218	CbGpPWpGaD
Ranitidine—Dyspnoea—Hydroxyurea—brain cancer	0.0007	0.00317	CcSEcCtD
Ranitidine—Somnolence—Hydroxyurea—brain cancer	0.000698	0.00316	CcSEcCtD
Ranitidine—Ill-defined disorder—Temozolomide—brain cancer	0.000698	0.00315	CcSEcCtD
Ranitidine—Leukopenia—Carmustine—brain cancer	0.000696	0.00315	CcSEcCtD
Ranitidine—Anaemia—Temozolomide—brain cancer	0.000695	0.00314	CcSEcCtD
Ranitidine—Diarrhoea—Procarbazine—brain cancer	0.000694	0.00314	CcSEcCtD
Ranitidine—Agitation—Temozolomide—brain cancer	0.000691	0.00312	CcSEcCtD
Ranitidine—Angioedema—Temozolomide—brain cancer	0.000687	0.00311	CcSEcCtD
Ranitidine—HRH2—brain—brain cancer	0.000681	0.0219	CbGeAlD
Ranitidine—Malaise—Temozolomide—brain cancer	0.000678	0.00307	CcSEcCtD
Ranitidine—Vertigo—Temozolomide—brain cancer	0.000675	0.00305	CcSEcCtD
Ranitidine—Leukopenia—Temozolomide—brain cancer	0.000673	0.00304	CcSEcCtD
Ranitidine—Pain—Hydroxyurea—brain cancer	0.000672	0.00304	CcSEcCtD
Ranitidine—Constipation—Hydroxyurea—brain cancer	0.000672	0.00304	CcSEcCtD
Ranitidine—Dizziness—Procarbazine—brain cancer	0.000671	0.00303	CcSEcCtD
Ranitidine—Chest pain—Carmustine—brain cancer	0.000662	0.00299	CcSEcCtD
Ranitidine—Myalgia—Carmustine—brain cancer	0.000662	0.00299	CcSEcCtD
Ranitidine—Erythema multiforme—Etoposide—brain cancer	0.000653	0.00295	CcSEcCtD
Ranitidine—Feeling abnormal—Hydroxyurea—brain cancer	0.000647	0.00293	CcSEcCtD
Ranitidine—ABCB1—blood vessel—brain cancer	0.000646	0.0208	CbGeAlD
Ranitidine—Vomiting—Procarbazine—brain cancer	0.000645	0.00292	CcSEcCtD
Ranitidine—Confusional state—Carmustine—brain cancer	0.00064	0.00289	CcSEcCtD
Ranitidine—Arthralgia—Temozolomide—brain cancer	0.00064	0.00289	CcSEcCtD
Ranitidine—Myalgia—Temozolomide—brain cancer	0.00064	0.00289	CcSEcCtD
Ranitidine—Rash—Procarbazine—brain cancer	0.00064	0.00289	CcSEcCtD
Ranitidine—Dermatitis—Procarbazine—brain cancer	0.000639	0.00289	CcSEcCtD
Ranitidine—Headache—Procarbazine—brain cancer	0.000636	0.00287	CcSEcCtD
Ranitidine—Discomfort—Temozolomide—brain cancer	0.000632	0.00286	CcSEcCtD
Ranitidine—Thrombocytopenia—Carmustine—brain cancer	0.000622	0.00281	CcSEcCtD
Ranitidine—Body temperature increased—Hydroxyurea—brain cancer	0.000621	0.00281	CcSEcCtD
Ranitidine—Tachycardia—Carmustine—brain cancer	0.00062	0.0028	CcSEcCtD
Ranitidine—Confusional state—Temozolomide—brain cancer	0.000619	0.0028	CcSEcCtD
Ranitidine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000617	0.0192	CbGpPWpGaD
Ranitidine—Anaphylactic shock—Temozolomide—brain cancer	0.000614	0.00277	CcSEcCtD
Ranitidine—SLC22A1—endocrine gland—brain cancer	0.000613	0.0197	CbGeAlD
Ranitidine—Alopecia—Etoposide—brain cancer	0.000611	0.00276	CcSEcCtD
Ranitidine—SLC22A1—head—brain cancer	0.000605	0.0194	CbGeAlD
Ranitidine—Nausea—Procarbazine—brain cancer	0.000603	0.00273	CcSEcCtD
Ranitidine—Thrombocytopenia—Temozolomide—brain cancer	0.000601	0.00272	CcSEcCtD
Ranitidine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000594	0.0184	CbGpPWpGaD
Ranitidine—Hypotension—Carmustine—brain cancer	0.000593	0.00268	CcSEcCtD
Ranitidine—Hyperhidrosis—Temozolomide—brain cancer	0.000593	0.00268	CcSEcCtD
Ranitidine—Hypersensitivity—Hydroxyurea—brain cancer	0.000579	0.00262	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000578	0.00262	CcSEcCtD
Ranitidine—Insomnia—Carmustine—brain cancer	0.000574	0.0026	CcSEcCtD
Ranitidine—Dyspnoea—Carmustine—brain cancer	0.000566	0.00256	CcSEcCtD
Ranitidine—Somnolence—Carmustine—brain cancer	0.000564	0.00255	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000559	0.00253	CcSEcCtD
Ranitidine—Ill-defined disorder—Etoposide—brain cancer	0.000558	0.00252	CcSEcCtD
Ranitidine—SLC22A8—head—brain cancer	0.000556	0.0179	CbGeAlD
Ranitidine—Anaemia—Etoposide—brain cancer	0.000556	0.00251	CcSEcCtD
Ranitidine—Insomnia—Temozolomide—brain cancer	0.000555	0.00251	CcSEcCtD
Ranitidine—SLC22A1—central nervous system—brain cancer	0.000552	0.0177	CbGeAlD
Ranitidine—Dyspnoea—Temozolomide—brain cancer	0.000547	0.00247	CcSEcCtD
Ranitidine—Somnolence—Temozolomide—brain cancer	0.000545	0.00247	CcSEcCtD
Ranitidine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000544	0.0169	CbGpPWpGaD
Ranitidine—Constipation—Carmustine—brain cancer	0.000543	0.00245	CcSEcCtD
Ranitidine—Pain—Carmustine—brain cancer	0.000543	0.00245	CcSEcCtD
Ranitidine—Malaise—Etoposide—brain cancer	0.000542	0.00245	CcSEcCtD
Ranitidine—Vertigo—Etoposide—brain cancer	0.00054	0.00244	CcSEcCtD
Ranitidine—Leukopenia—Etoposide—brain cancer	0.000538	0.00243	CcSEcCtD
Ranitidine—Diarrhoea—Hydroxyurea—brain cancer	0.000537	0.00243	CcSEcCtD
Ranitidine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000531	0.0165	CbGpPWpGaD
Ranitidine—Constipation—Temozolomide—brain cancer	0.000525	0.00237	CcSEcCtD
Ranitidine—Pain—Temozolomide—brain cancer	0.000525	0.00237	CcSEcCtD
Ranitidine—Feeling abnormal—Carmustine—brain cancer	0.000523	0.00237	CcSEcCtD
Ranitidine—Dizziness—Hydroxyurea—brain cancer	0.000519	0.00235	CcSEcCtD
Ranitidine—Chest pain—Etoposide—brain cancer	0.000512	0.00232	CcSEcCtD
Ranitidine—SLC22A8—central nervous system—brain cancer	0.000508	0.0163	CbGeAlD
Ranitidine—Discomfort—Etoposide—brain cancer	0.000506	0.00229	CcSEcCtD
Ranitidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000506	0.0157	CbGpPWpGaD
Ranitidine—Feeling abnormal—Temozolomide—brain cancer	0.000506	0.00229	CcSEcCtD
Ranitidine—Body temperature increased—Carmustine—brain cancer	0.000502	0.00227	CcSEcCtD
Ranitidine—Abdominal pain—Carmustine—brain cancer	0.000502	0.00227	CcSEcCtD
Ranitidine—Vomiting—Hydroxyurea—brain cancer	0.000499	0.00226	CcSEcCtD
Ranitidine—Rash—Hydroxyurea—brain cancer	0.000495	0.00224	CcSEcCtD
Ranitidine—Confusional state—Etoposide—brain cancer	0.000495	0.00224	CcSEcCtD
Ranitidine—Dermatitis—Hydroxyurea—brain cancer	0.000495	0.00224	CcSEcCtD
Ranitidine—Headache—Hydroxyurea—brain cancer	0.000492	0.00222	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—brain cancer	0.000491	0.00222	CcSEcCtD
Ranitidine—CYP2D6—brainstem—brain cancer	0.000491	0.0158	CbGeAlD
Ranitidine—Urticaria—Temozolomide—brain cancer	0.000487	0.0022	CcSEcCtD
Ranitidine—Body temperature increased—Temozolomide—brain cancer	0.000485	0.00219	CcSEcCtD
Ranitidine—Abdominal pain—Temozolomide—brain cancer	0.000485	0.00219	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—brain cancer	0.000481	0.00217	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—brain cancer	0.000479	0.00217	CcSEcCtD
Ranitidine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000476	0.0148	CbGpPWpGaD
Ranitidine—Hyperhidrosis—Etoposide—brain cancer	0.000475	0.00215	CcSEcCtD
Ranitidine—CYP2C19—endocrine gland—brain cancer	0.000472	0.0152	CbGeAlD
Ranitidine—Hypersensitivity—Carmustine—brain cancer	0.000468	0.00211	CcSEcCtD
Ranitidine—Nausea—Hydroxyurea—brain cancer	0.000467	0.00211	CcSEcCtD
Ranitidine—Hypotension—Etoposide—brain cancer	0.000459	0.00207	CcSEcCtD
Ranitidine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000458	0.0142	CbGpPWpGaD
Ranitidine—Hypersensitivity—Temozolomide—brain cancer	0.000452	0.00204	CcSEcCtD
Ranitidine—SLC22A1—brain—brain cancer	0.000438	0.0141	CbGeAlD
Ranitidine—Dyspnoea—Etoposide—brain cancer	0.000438	0.00198	CcSEcCtD
Ranitidine—Somnolence—Etoposide—brain cancer	0.000436	0.00197	CcSEcCtD
Ranitidine—CYP2D6—telencephalon—brain cancer	0.000436	0.014	CbGeAlD
Ranitidine—Diarrhoea—Carmustine—brain cancer	0.000434	0.00196	CcSEcCtD
Ranitidine—Pruritus—Temozolomide—brain cancer	0.000434	0.00196	CcSEcCtD
Ranitidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000426	0.0132	CbGpPWpGaD
Ranitidine—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00042	0.013	CbGpPWpGaD
Ranitidine—Dizziness—Carmustine—brain cancer	0.00042	0.0019	CcSEcCtD
Ranitidine—Pain—Etoposide—brain cancer	0.00042	0.0019	CcSEcCtD
Ranitidine—Constipation—Etoposide—brain cancer	0.00042	0.0019	CcSEcCtD
Ranitidine—Diarrhoea—Temozolomide—brain cancer	0.00042	0.0019	CcSEcCtD
Ranitidine—Dizziness—Temozolomide—brain cancer	0.000406	0.00183	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—brain cancer	0.000405	0.00183	CcSEcCtD
Ranitidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000404	0.0125	CbGpPWpGaD
Ranitidine—Vomiting—Carmustine—brain cancer	0.000404	0.00183	CcSEcCtD
Ranitidine—SLC22A8—brain—brain cancer	0.000403	0.013	CbGeAlD
Ranitidine—Rash—Carmustine—brain cancer	0.0004	0.00181	CcSEcCtD
Ranitidine—Dermatitis—Carmustine—brain cancer	0.0004	0.00181	CcSEcCtD
Ranitidine—Headache—Carmustine—brain cancer	0.000398	0.0018	CcSEcCtD
Ranitidine—Vomiting—Temozolomide—brain cancer	0.00039	0.00176	CcSEcCtD
Ranitidine—Urticaria—Etoposide—brain cancer	0.00039	0.00176	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—brain cancer	0.000388	0.00175	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—brain cancer	0.000388	0.00175	CcSEcCtD
Ranitidine—Rash—Temozolomide—brain cancer	0.000387	0.00175	CcSEcCtD
Ranitidine—Dermatitis—Temozolomide—brain cancer	0.000387	0.00175	CcSEcCtD
Ranitidine—CYP1A2—endocrine gland—brain cancer	0.000386	0.0124	CbGeAlD
Ranitidine—Headache—Temozolomide—brain cancer	0.000384	0.00174	CcSEcCtD
Ranitidine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000381	0.0118	CbGpPWpGaD
Ranitidine—Nausea—Carmustine—brain cancer	0.000377	0.00171	CcSEcCtD
Ranitidine—CYP3A5—endocrine gland—brain cancer	0.000372	0.012	CbGeAlD
Ranitidine—Nausea—Temozolomide—brain cancer	0.000364	0.00165	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—brain cancer	0.000362	0.00164	CcSEcCtD
Ranitidine—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000361	0.0112	CbGpPWpGaD
Ranitidine—Pruritus—Etoposide—brain cancer	0.000347	0.00157	CcSEcCtD
Ranitidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000345	0.0107	CbGpPWpGaD
Ranitidine—Diarrhoea—Etoposide—brain cancer	0.000336	0.00152	CcSEcCtD
Ranitidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000329	0.0102	CbGpPWpGaD
Ranitidine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000327	0.0102	CbGpPWpGaD
Ranitidine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000325	0.0101	CbGpPWpGaD
Ranitidine—Dizziness—Etoposide—brain cancer	0.000325	0.00147	CcSEcCtD
Ranitidine—ABCB1—telencephalon—brain cancer	0.000313	0.0101	CbGeAlD
Ranitidine—Vomiting—Etoposide—brain cancer	0.000312	0.00141	CcSEcCtD
Ranitidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000312	0.00968	CbGpPWpGaD
Ranitidine—Rash—Etoposide—brain cancer	0.00031	0.0014	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—brain cancer	0.000309	0.0014	CcSEcCtD
Ranitidine—Headache—Etoposide—brain cancer	0.000308	0.00139	CcSEcCtD
Ranitidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000303	0.0094	CbGpPWpGaD
Ranitidine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000299	0.00927	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000297	0.00921	CbGpPWpGaD
Ranitidine—Nausea—Etoposide—brain cancer	0.000292	0.00132	CcSEcCtD
Ranitidine—CYP3A4—endocrine gland—brain cancer	0.000279	0.00897	CbGeAlD
Ranitidine—CYP2D6—endocrine gland—brain cancer	0.000275	0.00883	CbGeAlD
Ranitidine—CYP2D6—head—brain cancer	0.000271	0.00872	CbGeAlD
Ranitidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000267	0.00828	CbGpPWpGaD
Ranitidine—ABCB1—gonad—brain cancer	0.000262	0.00841	CbGeAlD
Ranitidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000256	0.00796	CbGpPWpGaD
Ranitidine—ABCB1—pituitary gland—brain cancer	0.000255	0.0082	CbGeAlD
Ranitidine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000253	0.00786	CbGpPWpGaD
Ranitidine—CYP3A4—central nervous system—brain cancer	0.000252	0.00809	CbGeAlD
Ranitidine—CYP2D6—central nervous system—brain cancer	0.000248	0.00796	CbGeAlD
Ranitidine—ABCB1—medulla oblongata—brain cancer	0.000246	0.00791	CbGeAlD
Ranitidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000245	0.00762	CbGpPWpGaD
Ranitidine—CYP2D6—cerebellum—brain cancer	0.000242	0.00778	CbGeAlD
Ranitidine—HRH2—GPCR ligand binding—PTCH2—brain cancer	0.000237	0.00736	CbGpPWpGaD
Ranitidine—ABCB1—midbrain—brain cancer	0.000225	0.00723	CbGeAlD
Ranitidine—ABCB1—spinal cord—brain cancer	0.00022	0.00706	CbGeAlD
Ranitidine—HRH2—GPCR downstream signaling—OR4C12—brain cancer	0.000208	0.00646	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—OR14C36—brain cancer	0.000208	0.00646	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000208	0.00645	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000207	0.00642	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000198	0.00614	CbGpPWpGaD
Ranitidine—ABCB1—endocrine gland—brain cancer	0.000198	0.00635	CbGeAlD
Ranitidine—CYP2D6—brain—brain cancer	0.000197	0.00632	CbGeAlD
Ranitidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000195	0.00606	CbGpPWpGaD
Ranitidine—ABCB1—head—brain cancer	0.000195	0.00627	CbGeAlD
Ranitidine—HRH2—Signaling by GPCR—OR14C36—brain cancer	0.000189	0.00587	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—OR4C12—brain cancer	0.000189	0.00587	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000184	0.00573	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000183	0.00569	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000181	0.00561	CbGpPWpGaD
Ranitidine—ABCB1—central nervous system—brain cancer	0.000178	0.00572	CbGeAlD
Ranitidine—ABCB1—cerebellum—brain cancer	0.000174	0.0056	CbGeAlD
Ranitidine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000168	0.00522	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00016	0.00498	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.00016	0.00498	CbGpPWpGaD
Ranitidine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000149	0.00463	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000142	0.0044	CbGpPWpGaD
Ranitidine—ABCB1—brain—brain cancer	0.000141	0.00454	CbGeAlD
Ranitidine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.00014	0.00434	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000137	0.00425	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.00013	0.00405	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000129	0.00401	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000129	0.00399	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—SHH—brain cancer	0.000122	0.00379	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PTCH2—brain cancer	0.000122	0.00378	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—SMO—brain cancer	0.000116	0.0036	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—PTCH1—brain cancer	0.000116	0.0036	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000114	0.00354	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—OR14C36—brain cancer	0.000112	0.00346	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—OR4C12—brain cancer	0.000112	0.00346	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.00011	0.00343	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000109	0.00338	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—ABR—brain cancer	0.000105	0.00327	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000104	0.00323	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ABR—brain cancer	9.55e-05	0.00297	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—DTX2—brain cancer	9.49e-05	0.00295	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	8.81e-05	0.00274	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.52e-05	0.00265	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.4e-05	0.00261	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	7.4e-05	0.0023	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	7.35e-05	0.00228	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTCH2—brain cancer	7.19e-05	0.00223	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	6.97e-05	0.00216	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HES5—brain cancer	6.96e-05	0.00216	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STRADA—brain cancer	6.76e-05	0.0021	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—TRPC6—brain cancer	6.66e-05	0.00207	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	6.57e-05	0.00204	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—SHH—brain cancer	6.27e-05	0.00195	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	6.09e-05	0.00189	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—TRPC6—brain cancer	6.05e-05	0.00188	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PTCH1—brain cancer	5.94e-05	0.00185	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—SMO—brain cancer	5.94e-05	0.00185	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.92e-05	0.00184	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.88e-05	0.00183	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ABR—brain cancer	5.64e-05	0.00175	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	5.51e-05	0.00171	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GLI2—brain cancer	5.45e-05	0.00169	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.44e-05	0.00169	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GLI1—brain cancer	5.12e-05	0.00159	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	5.03e-05	0.00156	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—VAV1—brain cancer	4.99e-05	0.00155	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SUFU—brain cancer	4.86e-05	0.00151	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.83e-05	0.0015	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL2—brain cancer	4.81e-05	0.00149	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.8e-05	0.00149	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.74e-05	0.00147	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.72e-05	0.00147	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GFAP—brain cancer	4.69e-05	0.00146	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.68e-05	0.00145	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	4.63e-05	0.00144	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—VAV1—brain cancer	4.53e-05	0.00141	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	4.52e-05	0.0014	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	4.52e-05	0.0014	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HEY1—brain cancer	4.44e-05	0.00138	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—DLL1—brain cancer	4.36e-05	0.00135	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	4.35e-05	0.00135	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.24e-05	0.00132	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	4.14e-05	0.00129	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—VEGFA—brain cancer	4.09e-05	0.00127	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP2C9—brain cancer	4.04e-05	0.00125	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.98e-05	0.00124	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SHH—brain cancer	3.7e-05	0.00115	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.58e-05	0.00111	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TRPC6—brain cancer	3.57e-05	0.00111	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SMO—brain cancer	3.51e-05	0.00109	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTCH1—brain cancer	3.51e-05	0.00109	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—BSG—brain cancer	3.43e-05	0.00107	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.37e-05	0.00105	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CG—brain cancer	3.17e-05	0.000984	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP2C9—brain cancer	3.13e-05	0.000973	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.1e-05	0.000962	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—IDH1—brain cancer	2.95e-05	0.000916	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CG—brain cancer	2.88e-05	0.000893	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.81e-05	0.000874	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH2—brain cancer	2.81e-05	0.000872	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VAV1—brain cancer	2.68e-05	0.000831	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—BSG—brain cancer	2.66e-05	0.000827	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.62e-05	0.000813	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.42e-05	0.000752	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2C9—brain cancer	2.37e-05	0.000734	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ENO2—brain cancer	2.33e-05	0.000724	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.31e-05	0.000718	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HES1—brain cancer	2.3e-05	0.000715	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—IDH1—brain cancer	2.29e-05	0.000712	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.29e-05	0.000711	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2—brain cancer	2.23e-05	0.000692	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2C9—brain cancer	2.23e-05	0.000692	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PDGFRA—brain cancer	2.19e-05	0.00068	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SPP1—brain cancer	2.13e-05	0.000661	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—BSG—brain cancer	2.06e-05	0.00064	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2—brain cancer	2.02e-05	0.000629	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.02e-05	0.000626	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—BSG—brain cancer	2.01e-05	0.000624	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IRS2—brain cancer	1.92e-05	0.000597	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—BSG—brain cancer	1.89e-05	0.000588	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.89e-05	0.000586	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.86e-05	0.000576	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.81e-05	0.000563	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ENO2—brain cancer	1.81e-05	0.000562	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—IDH1—brain cancer	1.77e-05	0.00055	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—IDH1—brain cancer	1.73e-05	0.000537	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CG—brain cancer	1.7e-05	0.000528	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APC—brain cancer	1.7e-05	0.000528	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—IDH1—brain cancer	1.63e-05	0.000506	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—BSG—brain cancer	1.61e-05	0.000498	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—brain cancer	1.55e-05	0.000481	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.52e-05	0.000473	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.46e-05	0.000452	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.44e-05	0.000448	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ENO2—brain cancer	1.4e-05	0.000435	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—IDH1—brain cancer	1.38e-05	0.000429	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ENO2—brain cancer	1.37e-05	0.000424	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RELA—brain cancer	1.33e-05	0.000412	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ERBB2—brain cancer	1.32e-05	0.00041	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO2—brain cancer	1.29e-05	0.0004	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—BSG—brain cancer	1.24e-05	0.000385	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—brain cancer	1.2e-05	0.000371	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—brain cancer	1.17e-05	0.000362	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CTNNB1—brain cancer	1.15e-05	0.000358	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.12e-05	0.000349	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO2—brain cancer	1.09e-05	0.000339	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.07e-05	0.000332	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH1—brain cancer	1.07e-05	0.000331	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—brain cancer	1.02e-05	0.000316	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—brain cancer	1.01e-05	0.000312	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—brain cancer	9.35e-06	0.00029	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—brain cancer	9.15e-06	0.000284	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO2—brain cancer	8.42e-06	0.000261	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—brain cancer	8.31e-06	0.000258	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—brain cancer	7.68e-06	0.000238	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—brain cancer	6.42e-06	0.000199	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—brain cancer	6.27e-06	0.000195	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.91e-06	0.000183	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—brain cancer	5.01e-06	0.000155	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.86e-06	0.00012	CbGpPWpGaD
